Enterprise League logo
CRISPR Therapeutics Logo

CRISPR Therapeutics

Boston, United States (US) · Science and Engineering

Do your work at CRISPR Therapeutics?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

Aug 2026

#Gene Editing

#Hematology

#Immuno-Oncology

CRISPR Therapeutics is a Science and Engineering company based in Boston, United States (US), founded in 2013, with 200-500 employees. CRISPR Therapeutics's profile is verified on Enterprise League.

Overview

Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.
Visit Official Website

Most teams do this before shortlisting


Contact Details

info@crisprtx.com

Boston, United States (US)

Founded

2013

Employees

200-500

Categories

Biotechnology

Keywords

#Gene Editing

#Hematology

#Immuno-Oncology

Awards

• 2026 OpenSee all

Companies teams usually look at after CRISPR Therapeutics

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.